Evidence map›Paper›PMID 31501353›Full record

ArticleBioscience reports2019

MiR-31 promotes Th22 differentiation through targeting Bach2 in coronary heart disease.

Rimao Huang, Xuliang Chen, Yadong Long, Ri Chen

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioscience reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Role of Th22 Cells in Human Viral Diseases.Frontiers in medicine · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Rimao HuangDepartment of Cardiovascular Surgery, Xiangya Hospital of Centre-south University, No.87 Xiangya Road, Kaifu District, Changsha 410008, Hunan, China.
Xuliang ChenDepartment of Cardiovascular Surgery, Xiangya Hospital of Centre-south University, No.87 Xiangya Road, Kaifu District, Changsha 410008, Hunan, China.
Yadong LongDepartment of Cardiovascular Surgery, Xiangya Hospital of Centre-south University, No.87 Xiangya Road, Kaifu District, Changsha 410008, Hunan, China.
Ri ChenDepartment of Cardiovascular Surgery, Xiangya Hospital of Centre-south University, No.87 Xiangya Road, Kaifu District, Changsha 410008, Hunan, China chenri0731@163.com.ORCID 0000-0001-5951-301X
Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present study was to investigate the role of miR-31 in Th22 differentiation in coronary heart disease (CHD). Th22 frequencies in peripheral blood of CHD patients and controls as well as in CD4

Indexed as

Basic Helix-Loop-Helix ProteinsBasic-Leucine Zipper Transcription FactorsCD4-Positive T-LymphocytesCell DifferentiationCoronary DiseaseFemaleGene Expression RegulationHumansInterleukin-22InterleukinsMaleMicroRNAsMiddle AgedProtein BindingReceptors, Aryl HydrocarbonT-LymphocytesAHR protein, humanBACH2 protein, humanBasic Helix-Loop-Helix ProteinsBasic-Leucine Zipper Transcription FactorsInterleukin-22InterleukinsMicroRNAsMIRN31 microRNA, humanReceptors, Aryl HydrocarbonBach2CHDmiR-31Th22 differentiation

Identifiers

PMID31501353
PMCPMC6753318
OpenAlexW2972498058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.